ABC/IBA
This article was originally published in The Gray Sheet
Executive Summary
Association of Biotechnology Companies and Industrial Biotechnology Association merging July 1 to form a single biotechnology trade association. ABC members gave the merger a unanimous endorsement at the ABC annual meeting April 12-16. Industrial Biotechnology Association members already had voted to support the merger, which will result in the formation of the Biotechnology Industry Organization. Former IBA and ABC staffs plan to move into new offices in Washington, D.C. by June. Carl Feldbaum, former president of Palomar Corporation, has been named to head the new organization.
You may also be interested in...
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.